Main menu

Characterising influenza type A and B virus genomes through whole-genome nanopore sequencing


Flu protocol overview

Overview

Influenza is a global health concern due to annual epidemics of the disease and its potential to cause a pandemic because of novel strain variants. Whole-genome sequencing enables ongoing surveillance and identification of new emergent strains and can therefore provide information to inform the development of seasonal vaccines.

This overview describes how to generate accurate whole-genome sequences of influenza A and B viruses by PCR amplification and multiplexed nanopore sequencing.

In this protocol overview, you will:

  • Learn the key steps in the sequencing protocol
  • Discover our sequencing workflow , starting from the recommended extraction method, through to primary analysis with EPI2ME
  • Find out our recommended sequencing kit and devices

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Nanopore technology

Subscribe to Nanopore updates Resources and publications What is the Nanopore Community

About Oxford Nanopore

News Company timeline Sustainability Leadership team Media resources & contacts For investors For partners Working at Oxford Nanopore Current vacancies Commercial information BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag